This network delves into key topics such as care settings, the deployment of digital technology, health technology assessment, personalized therapies, and high-cost drugs. It also explores reimbursement models, drug pricing benchmarks, and strategies for improving medical outcomes.
With participation from CEOs, CMOs, Heads of Provider Networks, Directors of Pharmacy, and Heads of Strategy, the network is a core component of iFHP, dedicated to advancing medical effectiveness and cost-effective care. We welcome anyone with an interest in these areas to join and contribute to our ongoing discussions and initiatives.
Anar Dossa and Jenni Noble serve as the chairs of the iFHP Medical Effectiveness and High-Cost Drugs Member Network, bringing extensive experience and expertise to the role.
Anar Dossa is the Director of Pharmacy Services at Pacific Blue Cross, with over 30 years in pharmacy. Her clinical focus is on diabetes, and she is a Certified Diabetes Educator. Anar has served as a Past Chair and Board Member with the College of Pharmacists of BC and is a Clinical Assistant Professor at UBC’s Faculty of Pharmaceutical Sciences.
Jenni Noble, Head of Oncology Management and Strategy at Medscheme, oversees the comprehensive oncology strategy for the Afrocentric Group. Her role encompasses the entire oncology care continuum, from screening and prevention to end-of-life care. Jenni focuses on member-centric care for Medscheme’s 3.7 million insured South Africans, including stakeholder relationships, network design, reimbursement models, and risk management.
Together, Anar and Jenni guide the network with their in-depth knowledge and commitment to advancing medical effectiveness and cost-effective care.
To join this exclusive member network click below or reach out to nicola@ifhp.com for more information.
